The present disclosure relates generally to devices and methods for removing blockages from blood vessels during intravascular medical treatments.
Clot retrieval devices are used in mechanical thrombectomy for endovascular intervention, often in cases where patients are suffering from conditions such as acute ischemic stroke (AIS), myocardial infarction (MI), and pulmonary embolism (PE). Acute obstructions can include a clot, misplaced devices, migrated devices, large emboli, and the like. Thromboembolism occurs when part or all of a thrombus breaks away from the blood vessel wall. This clot (now called an embolus) is then carried in the direction of blood flow. An ischemic stroke can result if the clot lodges in the cerebral vasculature. A pulmonary embolism can result if the clot originates in the venous system or in the right side of the heart and lodges in a pulmonary artery or branch thereof. Clots can also develop and block vessels locally without being released in the form of an embolus—this mechanism is common in the formation of coronary blockages.
There are significant challenges associated with designing clot retrieval devices that can deliver high levels of performance. First, there are a number of access challenges that make it difficult to deliver devices. In cases where access involves navigating the aortic arch (such as coronary or cerebral blockages) the configuration of the arch in some patients makes it difficult to position a guide catheter. These difficult arch configurations are classified as either type 2 or type 3 aortic arches with type 3 arches presenting the most difficulty.
The tortuosity challenge is even more severe in the arteries approaching the brain. For example, it is not unusual at the distal end of the internal carotid artery that the device will have to navigate a vessel segment with a 180° bend, a 90° bend, and a 360° bend in quick succession over a few centimeters of vessel. In the case of pulmonary embolisms, access is through the venous system and then through the right atrium and ventricle of the heart. The right ventricular outflow tract and pulmonary arteries are delicate vessels that can easily be damaged by inflexible or high profile devices. For these reasons it is desirable that the clot retrieval device be compatible with as low profile and flexible a guide catheter as possible.
Second, the vasculature in the area in which the clot can be lodged is often fragile and delicate. For example, neurovascular vessels can be more fragile than similarly sized vessels in other parts of the body and can be in a soft tissue bed. Excessive tensile forces applied on these vessels could result in perforations and hemorrhage. Pulmonary vessels can be larger than those of the cerebral vasculature, but are also delicate in nature, particularly more distal vessels.
Additionally, the clot can have any of a range of morphologies and consistencies. For example, the clot can be difficult to grip and improper grip can lead to fragmentation which can cause embolization. Long strands of softer clot material can also tend to lodge at bifurcations or trifurcations, resulting in multiple vessels being simultaneously occluded over significant lengths. More mature and organized clot material can be less compressible than softer fresher clot, and under the action of blood pressure it can distend the compliant vessel in which it is lodged. Furthermore, the properties of the clot can be significantly changed by the action of the devices interacting with it. In particular, compression of a blood clot can cause dehydration of the clot and can result in a dramatic increase in both clot stiffness and coefficient of friction.
Lastly, traditional clot retrieval devices employing a pinch mechanism to capture a clot can require the delivery microcatheter to be forward post deployment of the clot retrieval device in order to effectively pinch a clot using the device. However, this can add an additional step in the procedure, thereby resulting in a potentially cumbersome and non-optimal procedure. Due to the critical nature of such procedures, it can be critical to capture a clot in a timely and effective manner.
The challenges described above need to be overcome for devices to provide a high level of success in removing clot and restoring flow.
It is desirable for a clot retrieval device to remove a clot from cerebral arteries in patient suffering from AIS, from coronary native or graft vessels in patients suffering from MI, and from pulmonary arteries in patients from PE and from other peripheral arterial and venous vessels in which a clot is causing at least a partial occlusion. Example devices and methods presented herein may be suitable for at least some of such procedures and/or similar procedures.
An example clot retrieval device can have a constrained delivery configuration and a clot engaging configuration and can be configured to remove a clot from a blood vessel. The device can include a first expandable framework having a first plurality of struts that form a first body and a second expandable framework having a second plurality of struts that form a second body. In the clot engaging configuration, the first body can be configured to move from a first position to a second position in relation to the second body.
The first body can have a first inner diameter and the second body can have a second inner diameter. The first inner diameter and the second inner diameter can be substantially equal.
When the first body is in the first position, the first plurality of struts and the second plurality of struts can be disengaged such that a plurality of clot reception spaces are formed.
When the first body is in the second position, the first plurality of struts and the second plurality of struts can be engaged such that an average cross-sectional area of the plurality of clot reception spaces decreases upon movement of the first body from the first position to the second position.
The first plurality of struts can include a radially extending strut and the second plurality of struts can include an eye through which the radially extending strut radially extends. The eyelet and the radially extending strut can be configured such that when the first body moves from the first position to the second position, the radially extending strut engages the eyelet to inhibit the first plurality of struts from moving, in relation to the second plurality of struts, beyond the second position. Each eyelet can be tapered.
The clot retrieval device can include a polymer coating to engage the first plurality of struts and the second plurality of struts. The polymer coating can be configured to fail, thereby allowing the first body to move from the first position to the second position.
At least one polymer membrane can be affixed to the first plurality of struts and the second plurality of struts such that the polymer membrane is disposed between the first body and the second body.
The at least one polymer membrane can be in a folded configuration when the first body is in the first position and the at least one polymer membrane can transition to a stretched configuration when the first body moves proximally to the second position.
The clot retrieval device can include a third expandable framework having a third framework of struts that form a third body. The first body and the second body can at least partially surround the third body in the clot engaging configuration.
A proximal end of the clot retrieval device can include a plurality of expanded struts that form a collar.
The third framework of struts can include at least one disconnected strut.
The third body can include a plurality of clot reception spaces. The plurality of clot reception spaces can be configured to engage the clot.
Another example clot retrieval device can have a constrained delivery configuration and a clot engaging configuration and can be configured to remove a clot from a blood vessel. The device can include an inner expandable framework, an outer expandable framework, and a spring. The inner expandable framework can be affixed to a pull wire and can include a first plurality of struts that form an inner body. The outer expandable framework can be affixed to the pull wire and can include a second plurality of struts that form an outer body at least partially surrounding the inner body. The spring can be affixed to a distal end of the pull wire and can have a compressed configuration and an elongated configuration. In the clot engaging configuration, the inner body can be configured to move from a first position to a second position in relation to the outer body such that the spring transitions from the compressed configuration to the elongated configuration.
The outer expandable framework can include a plurality of clot reception spaces that are configured to pinch the clot between the inner body and the outer body when the inner body moves from the first position to the second position.
An example method to capture a clot can include deploying a clot retrieval device proximate the clot where the clot retrieval device includes a first expandable framework forming a first body and a second expandable framework forming a second body at least partially surrounding the first body. The method can further include moving the first body in relation to the second body to pinch at least a portion of the clot between the first body and the second body and capturing one or more fragments of the clot.
Moving the first body in relation to the second body to pinch at least a portion of the clot between the first body and the second body can include applying tension to a pull wire where the pull wire is in mechanical communication with the first body.
The method can further include retracting the first body and the second body simultaneously.
The clot retrieval device can further include a third expandable framework having a third plurality of struts that form a third body. The first body and the second body can at least partially surround the third body. In such configuration, the method can further include retracting the third body in a proximal direction to engage the first body and the third body.
The design and functionality described in this application is intended to be exemplary in nature and is not intended to limit the instant disclosure in any way. Those having skill in the pertinent art will appreciate that the teachings of the disclosure may be implemented in a variety of suitable forms, including those forms disclosed herein and additional forms known to those having skill in the art pertinent.
It will be apparent from the foregoing description that, while particular embodiments of the present disclosure have been illustrated and described, various modifications can be made without departing from the spirit and scope of the disclosure. For example, while the embodiments described herein refer to particular features, the disclosure includes embodiments having different combinations of features. The disclosure also includes embodiments that do not include all of the specific features described. Specific embodiments of the present disclosure are now described in detail with reference to the figures, wherein identical reference numbers indicate identical or functionality similar elements.
The terms “distal” or “proximal” are used in the following description with respect to a position or direction relative to the treating physician. “Distal” or “distally” are a position distant from or in a direction away from the physician. “Proximal” or “proximally” or “proximate” are a position near or in a direction toward the physician.
In the following description, numerous specific details are set forth. But it is to be understood that examples of the disclosed technology can be practiced without these specific details. In other instances, well-known methods, structures, and techniques have not been shown in detail in order not to obscure an understanding of this description. References to “one embodiment,” “an embodiment,” “example embodiment,” “some embodiments,” “certain embodiments,” “various embodiments,” “one example,” “an example,” “some examples,” “certain examples,” “various examples,” etc., indicate that the embodiment(s) and/or example(s) of the disclosed technology so described may include a particular feature, structure, or characteristic, but not every embodiment necessarily includes the particular feature, structure, or characteristic. Further, repeated use of the phrase “in one embodiment” or the like does not necessarily refer to the same embodiment, example, or implementation, although it may.
By “comprising” or “containing” or “including” or “having” is meant that at least the named compound, element, particle, configuration, or method step is present in the composition or device or method, but does not exclude the presence of other compounds, materials, particles, method steps, or configurations even if the other such compounds, material, particles, method steps, or configurations have the same function as what is named.
Throughout the specification and the claims, the following terms take at least the meanings explicitly associated herein, unless the context clearly dictates otherwise. The term “or” is intended to mean an inclusive “or.” Further, the terms “a,” “an,” and “the” are intended to mean one or more unless specified otherwise or clear from the context to be directed to a singular form.
Unless otherwise specified, the use of the ordinal adjectives “first,” “second,” “third,” etc., to describe a common object, merely indicate that different instances of like objects are being referred to, and are not intended to imply that the objects so described should be in a given sequence, either temporally, spatially, in ranking, or in any other manner.
As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values ±20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 99%.
As discussed herein, a “patient” or “subject” can be a human or any animal. It should be appreciated that an animal can be a variety of any applicable type, including, but not limited to, mammal, veterinarian animal, livestock animal or pet-type animal, etc. As an example, the animal can be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like).
Accessing the various vessels within the vascular, whether they are coronary, pulmonary, or cerebral, involves well-known procedural steps and the use of a number of conventional, commercially-available accessory products. These products, such as angiographic materials and guidewires are widely used in laboratory and medical procedures. When these products are employed in conjunction with the system and methods of this disclosure in the description below, their function and exact constitution are not described in detail.
The disclosed technology can generally include a clot removal device having a sliding cage (e.g., a first body) and an outer cage (e.g., a second body) radially surrounding the sliding cage. A pull wire can be affixed to the sliding cage such that upon tension being applied to the pull wire, the sliding cage can displace proximally and independently of the outer cage. Upon the sliding cage displacing proximally, the sliding cage and the outer cage can pinch the clot. In some instances, the clot removal device can further include an inner channel (e.g., third body). The outer cage and the sliding cage can radially surround the inner channel. Upon tension being applied, the inner channel can move proximally and independently of the outer cage and sliding cage. Subsequently, the sliding cage can move proximally in relation to the outer cage and independently of the outer cage. In such configuration the sliding cage and the outer cage can further pinch the clot and the clot can thereby become further integrated within the clot removal device. Accordingly, the efficient and effective removal of a clot from a blood vessel can be performed.
Referring now to the Figures,
The first expandable framework 102 and the second expandable framework 104 can be collapsible into a restraining sheath (e.g., a microcatheter) sized to traverse a clot or other obstruction. The clot retrieval device 100 can be positioned proximate the clot in a blood vessel. Optionally, the clot retrieval device 100 can traverse the clot such that a portion of the clot remove device 100 is forward in relation to the clot. The first expandable framework 102 and the second expandable framework 104 can each be configured to self-expand upon release from the restraining sheath. Upon release, the clot retrieval device 100 can transition from a constrained delivery configuration to the clot engaging configuration such that the clot retrieval device 100 can be subsequently used to facilitate clot removal, flow restoration, and or fragmentation protection.
Upon transitioning to the clot engaging configuration, the first plurality of struts 106 of the first expandable framework 102 can expand to form a first body 110. Similarly, the second plurality of struts 108 of the second expandable framework 104 can expand to form a second body 112. The second body 112 can at least partially radially surround the first body 110. Optionally, the second body 112 can entirely radially surround the first body 110.
Both the first expandable framework 102, including the first plurality of struts 106, and the second expandable framework 104, including the second plurality of struts 108, can preferably be made from a material capable of recovering its shape automatically once released from the constrained delivery configuration. A super-elastic or pseudo-elastic material such as Nitinol or an alloy of similar properties is particularly suitable. The material can have a high recoverable strain sufficient to resiliently collapse and expand as described herein. The material could be in many forms such as wire or strip or sheet or tube. A particularly suitable manufacturing process is to laser cut a Nitinol tube and then heat set and electropolish the resultant structure to create a framework of struts and connecting elements. For example, the first expandable framework 102 and the second expandable framework 104 can each be laser cut from a Nitinol tube having an outer diameter of approximately 0.40 millimeters. Each of the cells in the first and second expandable frameworks 102, 104 can be any of a range of shapes as understood by a person skilled in the pertinent art according to the teachings disclosed herein. The first and second expandable frameworks 102, 104 can be rendered visible under fluoroscopy through the addition of alloying elements or through a variety of other coatings or marker bands. For instance, the first and second expandable frameworks 102, 104 can include material and/or markers with radiopaque material including, but not limited to Barium Sulphate, Bismuth SubCarbonate, Barium OxyChloride, Gold, Tungsten, Platinum, Iridium, Tantalum, and alloys thereof. Specifically, in some examples, the first and second expandable frameworks 102, 104 can include radiopaque markers having an Iridium alloy, and more specifically a Platinum-Iridium alloy.
As illustrated in
A distal end of the first body 110 and the second body 112 can form a distal basket 122. The distal basket 122 can have a substantially conical shape and can mitigate and/or prevent captured fragments of a clot from migrating out of the clot retrieval device 100.
As further illustrated in
Additionally, or alternatively, the first expandable framework 102 and the second expandable framework 104 can be coated with a polymer coating (e.g., parylene) to temporarily hold the first body 110 in the first position in relation to the second body 112. Upon the pull wire 114 being pulled in the proximal direction, the polymer coating can fail such that the first body 110 can move from the first position to the second position in relation to the second body 112. Aspiration can be applied in order to remove particulate from the failed polymer coating.
Additionally, or alternatively, a shape memory effect of the first body 110 and the second body 112 can be used to cause automatic displacement of the first body 110 after a predetermined time period has lapsed. For example, the second plurality of struts 108 of the second expandable framework 104 can be heat treated locally to increase the austenite finish temperature to a range greater than a typical body temperature during a stroke or other critical body occurrence. The second plurality of struts 108 can expand upon being re-sheathed then be heated to the austenite finish temperature by electrical current. Upon the austenite finish temperature being reached, the first body 110 can automatic move (e.g., slide) in relation to the second body 112 from the first position to the second position, such that the clot can be pinched between the first body 110 and the second body 112.
The pull wire 114 can be pulled in the proximal direction such that the first body 110 moves (e.g., slides) in the proximal direction until the proximal struts of the first plurality of struts 106 encounter the joint 130 positioned proximate the shaft 132. As such, the joint 130 can act as a mechanism to prevent undesired movement beyond the second position. As the first body 110 moves from the first position to the second position the average cross-sectional area of the plurality of clot reception spaces 120 can decrease (e.g., at least partially close). For example, the plurality of clot reception spaces 120 can at least partially close when the first plurality of scaffolding segments 138a slide in relation to the second plurality of scaffolding segments 138b such that the first plurality of scaffolding segment 138a become disposed across the clot reception spaces 120. Thereby, the clot can be pinched between the first body 110 and the second body 112. Pinching of the clot can prevent the clot from migrating out of the clot retrieval device 100, particularly upon retraction of the clot retrieval device 100, as the pinch can increase the grip of the clot retrieval device 100 as compared to other clot retrieval devices, particularly fibrin rich clots. Accordingly, the clot retrieval device 100 can ensure effective and efficient removal of the clot from the patient.
As illustrated in
In contrast to the clot retrieval device 100 illustrated in
As discussed above with reference to the clot retrieval device 100, the first body 110 can include a first plurality of scaffolding segments 138a and the second body 112 can include a second plurality of scaffolding segments 138b. The first and second plurality of scaffolding segments 138a, 138b can substantially align with one another. A gap can be formed between each scaffolding segment of the first plurality and second plurality of scaffolding segments 138a, 138b. Such gap can be a clot reception space 120 configured to receive at least a portion of a clot upon the clot retrieval device 200 transitioning to a clot pinching configuration as further described herein. The configuration of the third body 206 can similarly create additional clot reception spaces 230 as further discussed herein.
The distal end of the clot retrieval device 200 can include the distal basket 122. The distal basket 122 can have a substantially conical shape and can mitigate captured fragments of a clot from migrating out of the clot retrieval device 200.
As further illustrated in
In order to pinch the clot using the clot retrieval device 200, the pull wire 114 can be pulled in a proximal direction. Such tension can cause the third body 206 to move (e.g., slide) in relation to the first body 110 and the second body 112 causing the clot retrieval device 200 to transition from the first position to the second position, as indicated by a first arrow 232. For example, the third body 206 can slide less than approximately 5 millimeters in relation to the first body 110 and the second body 112. Optionally, the third body 206 can slide less than approximately 4 millimeters in relation to the first body 110 and the second body 112. Optionally, the third body 206 can slide less than approximately 2 millimeters in relation to the first body 110 and the second body 112. Optionally, the third body 206 can slide less than approximately 0.5 millimeters in relation to the first body and the second body 112.
Upon the third body 206 moving in relation to the first body 110 and the second body 112, at least a portion of the clot can be pinched between the third body 206 and the first body 110 and the second body 112 to cause the portions of the clot to migrate inside the first body 110 and the second body 112. Additionally, upon the third body 206 moving from the first position to the second position, the third body 206 can become engaged with the first body 110 as the third collar 214 becomes engaged with the first collar 210. When the third collar 214 and the first collar 210 become engaged, the pull force can be transferred to the first body 110, thereby allowing for further displacement.
Subsequently, the first body 110 can move (e.g., slide) in relation to the second body 112 such that the clot retrieval device 200 transitions from the second position to the third position, as indicated by a second arrow 234. For example, the first body 110 can slide less than approximately 5 millimeters in relation to the second body 112. Optionally, the first body 110 can slide less than approximately 4 millimeters in relation to the second body 112. Optionally, the first body 110 can slide less than approximately 2 millimeters in relation to the second body 112. Optionally, the first body 110 can slide less than approximately 0.5 millimeters in relation to the second body 112.
Upon the first body 110 moving from the second position to the third position, the first body 110 engaged with the third body 206 can become engaged with the second body 112 causing an average cross-sectional area of the plurality of clot reception spaces 120 to decrease (e.g., at least partially close). Thereby, at least a portion of the clot can be further pinched. The portions of the clot can be pinched between the first body 110 and the second body 112 and, additionally, the third body 206. Accordingly, the portions of the clot can further migrate inside third body 206. As such, the portions of the clot can further migrate into the clot reception spaces 230 of the third body 206. Upon transitioning to the third position, the expanded struts 208a, 208b can become resheathed as the first collar 210 becomes engaged with the second collar 212. When the first collar 210 becomes engaged with the second collar 212, the pull force can be transferred to the second body 112. Accordingly, the first body 110, the second body 112, and the third body 206, including the captured clot or portions thereof, can be removed simultaneously from the patient's vasculature.
Optionally, the clot retrieval device 200 can include a seal that allows the clot retrieval device 200 to maintain a pinch even if the physician stops applying tension. For example, the clot retrieval device 200 can include a seal disposed proximate the weld joint 220. The seal can maintain the clot retrieval device 200 in place using friction. As such, the seal can create enough static friction such that the clot removal device 200 does not displace when a physician stops applying tension while also ensuring the static friction is not too high that a user cannot overcome such static friction when manipulating the clot retrieval device 200 during retrieval of the clot and removal of the clot retrieval device 200 from a patient.
The inner body 310 and the outer body 312 can have different inner diameters 330, 332 and/or configurations. For example, the inner body 310 can have a smaller inner diameter 330 than the inner diameter 332 of the outer body 312, as such the outer body 312 can radially surround the inner body 310. Optionally, the inner diameter 330 of the inner body 310 can be approximately half of the size of the inner diameter 332 of the outer body 312. Optionally, the inner diameter 330 of the inner body 310 can be approximately ¾ of the size of the inner diameter 332 of the outer body 312. As illustrated in
The inner body 310 and the outer body 312 can each be affixed to a pull wire 314. The pull wire 314 can include a first stopper 322 and a second stopper 324 at a proximal end 326 of the pull wire. The first stopper 322 can be disposed distally in relation to the second stopper 324.
A spring 316 can be affixed to a distal end 318 of the pull wire 314. The spring 316 can be configured to transition from a compressed configuration and an elongated configuration upon actuation. The spring 316 can be configured to maintain a central position of the inner body 310 within the outer body 312. In the previously illustrated clot retrieval devices 100, 200 because the first body 110 has an approximately equal inner diameter 134 to the second body 112, the first body 110 resides centrally within the second body 112 because of outward force from the first body 110 onto the second body 112. When the inner body 310 has a substantially smaller inner diameter 330 than the outer body 312 as illustrated in
As illustrated in
The method 400 can further include moving 404 (e.g., sliding) the first body 110 proximally in relation to the second body 112 to pinch at least a portion of the clot between the first body 110 and the second body 112 such that the clot removal device 100 transitions to a clot pinching configuration. By way of example, tension can be applied to the pull wire 114 until the first body 110 encounters the joint 130. As the pull wire 114 is pulled in the proximal direction, the first body 110 can move in the proximal direction in relation to the second body 112, thereby pinching at least a portion of the clot between the first body 110 and the second body 112.
The method 400 can further include capturing 406 one or more fragments of the clot.
Additionally, the method 400 can include retracting the first body 110 and the second body 112 simultaneously, as the first body 110 and the second body 112 become engaged upon the first body 110 moving in relation to the second body 112. Similarly, upon the first body 110 and the second body 112 being retracted into a restraining sheath, the restraining sheath can be removed from a patient's vasculature.
The method 500 can further include moving 504 (e.g., sliding) the third body 206 in relation to the first body 110 and the second body 112 to pinch at least a portion of the clot between the third body 206 and the first body 110 and the second body 112 such that the clot removal device 200 transitions to a clot pinching configuration. As such, at least a portion of the clot can migrate into the first body 110 and the second body 112. Upon moving the third body 206 in relation to the first body 110 and the second body 112, the third body 206 can become engaged with the first body 110.
The method 500 can further include moving 506 (e.g., sliding) the first body 110 proximally in relation to the second body 112 to further pinch at least a portion of the clot between the third body 206 and the first body 110 and the second body 112. As the first body 110 moves in relation to the second body 112, the average cross-sectional area of the clot reception spaces 120 can decrease, thereby pinching at least a portion of clot and preventing and/or mitigating the captured portions of the clot from migrating back out of the clot retrieval device 200. Upon pinching the clot, at least a portion of the clot can migrate inside the third body 206. When at least a portion of the clot is within third body 206, the potential for the portions of the captured clot to migrate back out of the clot retrieval device 200 can decrease.
The method 500 can further include capturing 508 one or more fragments of the clot.
Additionally, the method 500 can include simultaneously retracting the first body 110, the second body 112, and the third body 206. Upon being retracted into a delivery microcatheter, the delivery microcatheter can be removed from a patient's vasculature, and thus, the clot can be removed effectively and efficiently from the patient's vasculature.
Certain examples and implementations of the disclosed technology are described above with reference to block and flow diagrams according to examples of the disclosed technology. It will be understood that one or more blocks of the block diagrams and flow diagrams, and combinations of blocks in the block diagrams and flow diagrams, respectively. Likewise, some blocks of the block diagrams and flow diagrams do not necessarily need to be performed in the order presented, can be repeated, or do not necessarily need to be performed at all, according to some examples or implementations of the disclosed technology. It is also to be understood that the mention of one or more method steps does not preclude the presence of additional method steps or intervening method steps between those steps expressly identified. Additionally, method steps from one process flow diagram or block diagram can be combined with method steps from another process diagram or block diagram. These combinations and/or modifications are contemplated herein.
Number | Name | Date | Kind |
---|---|---|---|
2828147 | Peiffer | Dec 1899 | A |
3361460 | Gerhart et al. | Jan 1968 | A |
4455717 | Gray | Jun 1984 | A |
4611594 | Grayhack et al. | Sep 1986 | A |
4612931 | Dormia | Sep 1986 | A |
4643184 | Mobin-Uddin | Feb 1987 | A |
4727873 | Mobin-Uddin | Mar 1988 | A |
4793348 | Palmaz | Dec 1988 | A |
4873978 | Ginsburg | Oct 1989 | A |
5011488 | Ginsburg | Apr 1991 | A |
5084065 | David et al. | Jan 1992 | A |
5092839 | Kipperman | Mar 1992 | A |
5100423 | Fearnot | Mar 1992 | A |
5102415 | Guenther et al. | Apr 1992 | A |
5108419 | Reger et al. | Apr 1992 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5163951 | Pinchuk et al. | Nov 1992 | A |
5171233 | Amplatz et al. | Dec 1992 | A |
5171259 | Inoue | Dec 1992 | A |
5217441 | Shichman | Jun 1993 | A |
5234437 | Sepetka | Aug 1993 | A |
5236447 | Kubo et al. | Aug 1993 | A |
5330482 | Gibbs et al. | Jul 1994 | A |
5383887 | Nadal | Jan 1995 | A |
5387219 | Rappe | Feb 1995 | A |
5387226 | Miraki | Feb 1995 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5499985 | Hein et al. | Mar 1996 | A |
5538512 | Zenzon et al. | Jul 1996 | A |
5538515 | Kafry et al. | Jul 1996 | A |
5549626 | Miller et al. | Aug 1996 | A |
5558652 | Henke | Sep 1996 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5624461 | Mariant | Apr 1997 | A |
5639277 | Mariant et al. | Jun 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5645558 | Horton | Jul 1997 | A |
5653605 | Woehl et al. | Aug 1997 | A |
5658296 | Bates et al. | Aug 1997 | A |
5665117 | Rhodes | Sep 1997 | A |
5695519 | Summers et al. | Dec 1997 | A |
5709704 | Nott et al. | Jan 1998 | A |
5713853 | Clark et al. | Feb 1998 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5769871 | Mers Kelly et al. | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5779686 | Sato et al. | Jul 1998 | A |
5779716 | Cano et al. | Jul 1998 | A |
5800519 | Sandock | Sep 1998 | A |
5810874 | Lefebvre | Sep 1998 | A |
5814064 | Daniel et al. | Sep 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5827304 | Hart | Oct 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5855598 | Pinchuk | Jan 1999 | A |
5893869 | Barnhart et al. | Apr 1999 | A |
5895398 | Wensel et al. | Apr 1999 | A |
5897567 | Ressemann et al. | Apr 1999 | A |
5904698 | Thomas et al. | May 1999 | A |
5911702 | Romley et al. | Jun 1999 | A |
5911725 | Boury | Jun 1999 | A |
5919126 | Armini | Jul 1999 | A |
5931509 | Bartholomew | Aug 1999 | A |
5935139 | Bates | Aug 1999 | A |
5947995 | Samuels | Sep 1999 | A |
6063113 | Kavteladze et al. | May 2000 | A |
6066149 | Samson et al. | May 2000 | A |
6066158 | Engelson et al. | May 2000 | A |
6093196 | Okada | Jul 2000 | A |
6093199 | Brown et al. | Jul 2000 | A |
6096053 | Bates | Aug 2000 | A |
6099534 | Bates et al. | Aug 2000 | A |
6099559 | Nolting | Aug 2000 | A |
6102932 | Kurz | Aug 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6129739 | Khosravi | Oct 2000 | A |
6143022 | Shull et al. | Nov 2000 | A |
6146404 | Kim et al. | Nov 2000 | A |
6156064 | Chouinard | Dec 2000 | A |
6165194 | Denardo | Dec 2000 | A |
6165199 | Barbut | Dec 2000 | A |
6168604 | Cano | Jan 2001 | B1 |
6168622 | Mazzocchi | Jan 2001 | B1 |
6174318 | Bates et al. | Jan 2001 | B1 |
6179861 | Khosravi et al. | Jan 2001 | B1 |
6203561 | Ramee et al. | Mar 2001 | B1 |
6214026 | Lepak et al. | Apr 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6221096 | Aiba et al. | Apr 2001 | B1 |
6231597 | Deem et al. | May 2001 | B1 |
6238412 | Dubrul et al. | May 2001 | B1 |
6245012 | Kleshinski | Jun 2001 | B1 |
6245087 | Addis | Jun 2001 | B1 |
6251122 | Tsukernik | Jun 2001 | B1 |
6254571 | Hart | Jul 2001 | B1 |
6264663 | Cano | Jul 2001 | B1 |
6267777 | Bosma et al. | Jul 2001 | B1 |
6290710 | Cryer et al. | Sep 2001 | B1 |
6312444 | Barbut | Nov 2001 | B1 |
6315778 | Gambale et al. | Nov 2001 | B1 |
6325815 | Kusleika et al. | Dec 2001 | B1 |
6325819 | Pavcnik et al. | Dec 2001 | B1 |
6334864 | Amplatz et al. | Jan 2002 | B1 |
6336934 | Gilson et al. | Jan 2002 | B1 |
6346116 | Brooks et al. | Feb 2002 | B1 |
6348056 | Bates et al. | Feb 2002 | B1 |
6350271 | Kurz et al. | Feb 2002 | B1 |
6355057 | DeMarais et al. | Mar 2002 | B1 |
6361545 | Macoviak et al. | Mar 2002 | B1 |
6364895 | Greenhalgh | Apr 2002 | B1 |
6375668 | Gifford et al. | Apr 2002 | B1 |
6375670 | Greenhalgh | Apr 2002 | B1 |
6383205 | Samson et al. | May 2002 | B1 |
6383206 | Gillick et al. | May 2002 | B1 |
6391037 | Greenhalgh | May 2002 | B1 |
6402771 | Palmer et al. | Jun 2002 | B1 |
6416541 | Denardo | Jul 2002 | B2 |
6425909 | Dieck et al. | Jul 2002 | B1 |
6428558 | Jones et al. | Aug 2002 | B1 |
6432122 | Gilson et al. | Aug 2002 | B1 |
6436112 | Wensel et al. | Aug 2002 | B2 |
6458139 | Palmer et al. | Oct 2002 | B1 |
6485497 | Wensel et al. | Nov 2002 | B2 |
6485501 | Green | Nov 2002 | B1 |
6485502 | Don Michael et al. | Nov 2002 | B2 |
6488701 | Nolting et al. | Dec 2002 | B1 |
6511492 | Rosenbluth et al. | Jan 2003 | B1 |
6530935 | Wensel et al. | Mar 2003 | B2 |
6530939 | Hopkins et al. | Mar 2003 | B1 |
6540768 | Diaz et al. | Apr 2003 | B1 |
6544279 | Hopkins et al. | Apr 2003 | B1 |
6551341 | Boylan et al. | Apr 2003 | B2 |
6551342 | Shen et al. | Apr 2003 | B1 |
6575996 | Denison et al. | Jun 2003 | B1 |
6575997 | Palmer et al. | Jun 2003 | B1 |
6582448 | Boyle et al. | Jun 2003 | B1 |
6585756 | Strecker | Jul 2003 | B1 |
6589265 | Palmer et al. | Jul 2003 | B1 |
6592607 | Palmer et al. | Jul 2003 | B1 |
6592614 | Lenker et al. | Jul 2003 | B2 |
6592616 | Stack et al. | Jul 2003 | B1 |
6598265 | Lee | Jul 2003 | B2 |
6602265 | Dubrul et al. | Aug 2003 | B2 |
6602271 | Adams et al. | Aug 2003 | B2 |
6602272 | Boylan et al. | Aug 2003 | B2 |
6605102 | Mazzocchi et al. | Aug 2003 | B1 |
6610077 | Hancock et al. | Aug 2003 | B1 |
6616679 | Khosravi et al. | Sep 2003 | B1 |
6632241 | Hancock et al. | Oct 2003 | B1 |
6638245 | Miller et al. | Oct 2003 | B2 |
6638293 | Makower et al. | Oct 2003 | B1 |
6641590 | Palmer et al. | Nov 2003 | B1 |
6656218 | Denardo et al. | Dec 2003 | B1 |
6660021 | Palmer et al. | Dec 2003 | B1 |
6663650 | Sepetka et al. | Dec 2003 | B2 |
6673089 | Yassour et al. | Jan 2004 | B1 |
6685722 | Rosenbluth et al. | Feb 2004 | B1 |
6692504 | Kurz et al. | Feb 2004 | B2 |
6692508 | Wensel et al. | Feb 2004 | B2 |
6692509 | Wensel et al. | Feb 2004 | B2 |
6695858 | Dubrul et al. | Feb 2004 | B1 |
6702782 | Miller et al. | Mar 2004 | B2 |
6702834 | Boylan et al. | Mar 2004 | B1 |
6709465 | Mitchell et al. | Mar 2004 | B2 |
6712834 | Yassour et al. | Mar 2004 | B2 |
6726701 | Gilson et al. | Apr 2004 | B2 |
6726703 | Broome et al. | Apr 2004 | B2 |
6730104 | Sepetka et al. | May 2004 | B1 |
6783528 | Vincent-Prestigiacomo | Aug 2004 | B2 |
6783538 | McGuckin, Jr. et al. | Aug 2004 | B2 |
6824545 | Sepetka et al. | Nov 2004 | B2 |
6855155 | Denardo et al. | Feb 2005 | B2 |
6878163 | Denardo et al. | Apr 2005 | B2 |
6890340 | Duane | May 2005 | B2 |
6913612 | Palmer et al. | Jul 2005 | B2 |
6913618 | Denardo et al. | Jul 2005 | B2 |
6939361 | Kleshinski | Sep 2005 | B1 |
6953472 | Palmer et al. | Oct 2005 | B2 |
6989019 | Mazzocchi et al. | Jan 2006 | B2 |
6989021 | Bosma et al. | Jan 2006 | B2 |
6994718 | Groothuis et al. | Feb 2006 | B2 |
7004954 | Voss et al. | Feb 2006 | B1 |
7004955 | Shen et al. | Feb 2006 | B2 |
7004956 | Palmer et al. | Feb 2006 | B2 |
7008434 | Kurz et al. | Mar 2006 | B2 |
7033376 | Tsukernik | Apr 2006 | B2 |
7041116 | Goto et al. | May 2006 | B2 |
7048758 | Boyle et al. | May 2006 | B2 |
7052500 | Bashiri et al. | May 2006 | B2 |
7058456 | Pierce | Jun 2006 | B2 |
7063707 | Bose et al. | Jun 2006 | B2 |
7083633 | Morrill et al. | Aug 2006 | B2 |
7083822 | Brightbill | Aug 2006 | B2 |
7094249 | Broome et al. | Aug 2006 | B1 |
7097653 | Freudenthal et al. | Aug 2006 | B2 |
7101380 | Khachin et al. | Sep 2006 | B2 |
7172614 | Boyle et al. | Feb 2007 | B2 |
7175655 | Molaei | Feb 2007 | B1 |
7179273 | Palmer et al. | Feb 2007 | B1 |
7185922 | Takayanagi et al. | Mar 2007 | B2 |
7220271 | Clubb et al. | May 2007 | B2 |
7226464 | Garner et al. | Jun 2007 | B2 |
7229472 | DePalma et al. | Jun 2007 | B2 |
7241304 | Boyle et al. | Jul 2007 | B2 |
7241308 | Andreas et al. | Jul 2007 | B2 |
7288112 | Denardo et al. | Oct 2007 | B2 |
7300458 | Henkes et al. | Nov 2007 | B2 |
7306618 | Demond et al. | Dec 2007 | B2 |
7314483 | Andau et al. | Jan 2008 | B2 |
7316692 | Huffmaster | Jan 2008 | B2 |
7323001 | Clubb et al. | Jan 2008 | B2 |
7331976 | McGuckin, Jr. et al. | Feb 2008 | B2 |
7344550 | Carrison et al. | Mar 2008 | B2 |
7399308 | Borillo et al. | Jul 2008 | B2 |
7410491 | Hopkins et al. | Aug 2008 | B2 |
7425215 | Boyle et al. | Sep 2008 | B2 |
7452496 | Brady et al. | Nov 2008 | B2 |
7491215 | Vale et al. | Feb 2009 | B2 |
7491216 | Brady | Feb 2009 | B2 |
7510565 | Gilson et al. | Mar 2009 | B2 |
7534252 | Sepetka et al. | May 2009 | B2 |
7556636 | Mazzocchi et al. | Jul 2009 | B2 |
7582111 | Krolik et al. | Sep 2009 | B2 |
7594926 | Linder et al. | Sep 2009 | B2 |
7604649 | McGuckin, Jr. et al. | Oct 2009 | B2 |
7604650 | Bergheim | Oct 2009 | B2 |
7609649 | Bhandari et al. | Oct 2009 | B1 |
7618434 | Santra et al. | Nov 2009 | B2 |
7662165 | Gilson et al. | Feb 2010 | B2 |
7670356 | Mazzocchi et al. | Mar 2010 | B2 |
7678123 | Chanduszko | Mar 2010 | B2 |
7691121 | Rosenbluth et al. | Apr 2010 | B2 |
7691124 | Balgobin | Apr 2010 | B2 |
7708770 | Linder et al. | May 2010 | B2 |
7717929 | Fallman | May 2010 | B2 |
7736385 | Agnew | Jun 2010 | B2 |
7749246 | McGuckin, Jr. et al. | Jul 2010 | B2 |
7758606 | Streeter et al. | Jul 2010 | B2 |
7758611 | Kato | Jul 2010 | B2 |
7766934 | Pal et al. | Aug 2010 | B2 |
7771452 | Pal et al. | Aug 2010 | B2 |
7780694 | Palmer et al. | Aug 2010 | B2 |
7780700 | Frazier et al. | Aug 2010 | B2 |
7811305 | Balgobin et al. | Oct 2010 | B2 |
7815659 | Conlon et al. | Oct 2010 | B2 |
7819893 | Brady et al. | Oct 2010 | B2 |
7828815 | Mazzocchi et al. | Nov 2010 | B2 |
7828816 | Mazzocchi et al. | Nov 2010 | B2 |
7833240 | Okushi et al. | Nov 2010 | B2 |
7842053 | Chanduszko et al. | Nov 2010 | B2 |
7846175 | Bonnette et al. | Dec 2010 | B2 |
7846176 | Gilson et al. | Dec 2010 | B2 |
7850708 | Pal | Dec 2010 | B2 |
7883516 | Huang et al. | Feb 2011 | B2 |
7887560 | Kusleika | Feb 2011 | B2 |
7901426 | Gilson et al. | Mar 2011 | B2 |
7914549 | Morsi | Mar 2011 | B2 |
7922732 | Mazzocchi et al. | Apr 2011 | B2 |
7927784 | Simpson | Apr 2011 | B2 |
7931659 | Bose et al. | Apr 2011 | B2 |
7998165 | Huffmaster | Aug 2011 | B2 |
8002822 | Glocker et al. | Aug 2011 | B2 |
8021379 | Thompson et al. | Sep 2011 | B2 |
8021380 | Thompson et al. | Sep 2011 | B2 |
8043326 | Hancock et al. | Oct 2011 | B2 |
8048151 | OBrien et al. | Nov 2011 | B2 |
8052640 | Fiorella et al. | Nov 2011 | B2 |
8057497 | Raju et al. | Nov 2011 | B1 |
8057507 | Horan et al. | Nov 2011 | B2 |
8066757 | Ferrera et al. | Nov 2011 | B2 |
8070791 | Ferrera et al. | Dec 2011 | B2 |
8088140 | Ferrera et al. | Jan 2012 | B2 |
8100935 | Rosenbluth et al. | Jan 2012 | B2 |
8109941 | Richardson | Feb 2012 | B2 |
8118829 | Carrison et al. | Feb 2012 | B2 |
8118856 | Schreck et al. | Feb 2012 | B2 |
8123769 | Osborne | Feb 2012 | B2 |
8137376 | Clubb et al. | Mar 2012 | B2 |
8137377 | Palmer et al. | Mar 2012 | B2 |
8142422 | Makower et al. | Mar 2012 | B2 |
8142442 | Palmer et al. | Mar 2012 | B2 |
8182508 | Magnuson et al. | May 2012 | B2 |
8187298 | Pal | May 2012 | B2 |
8246641 | Osborne et al. | Aug 2012 | B2 |
8246672 | Osborne | Aug 2012 | B2 |
8252017 | Paul, Jr. et al. | Aug 2012 | B2 |
8252018 | Valaie | Aug 2012 | B2 |
8262689 | Schneiderman et al. | Sep 2012 | B2 |
8282668 | McGuckin, Jr. et al. | Oct 2012 | B2 |
8287538 | Brenzel et al. | Oct 2012 | B2 |
8298257 | Sepetka et al. | Oct 2012 | B2 |
RE43882 | Hopkins et al. | Dec 2012 | E |
8357178 | Grandfield et al. | Jan 2013 | B2 |
8357179 | Grandfield et al. | Jan 2013 | B2 |
8357180 | Feller, III et al. | Jan 2013 | B2 |
8357893 | Xu et al. | Jan 2013 | B2 |
8361095 | Osborne | Jan 2013 | B2 |
8361110 | Chanduszko | Jan 2013 | B2 |
8366663 | Fiorella et al. | Feb 2013 | B2 |
8409215 | Sepetka et al. | Apr 2013 | B2 |
8414482 | Belson | Apr 2013 | B2 |
8414543 | McGuckin, Jr. et al. | Apr 2013 | B2 |
8419748 | Valaie | Apr 2013 | B2 |
8460312 | Bose et al. | Jun 2013 | B2 |
8460313 | Huffmaster | Jun 2013 | B2 |
8486104 | Samson et al. | Jul 2013 | B2 |
8512352 | Martin | Aug 2013 | B2 |
8529596 | Grandfield et al. | Sep 2013 | B2 |
8545526 | Martin et al. | Oct 2013 | B2 |
8574262 | Ferrera et al. | Nov 2013 | B2 |
8574915 | Zhang et al. | Nov 2013 | B2 |
8579915 | French et al. | Nov 2013 | B2 |
8585713 | Ferrera et al. | Nov 2013 | B2 |
8608761 | Osborne et al. | Dec 2013 | B2 |
8679142 | Slee et al. | Mar 2014 | B2 |
8690907 | Janardhan et al. | Apr 2014 | B1 |
8696622 | Fiorella et al. | Apr 2014 | B2 |
8702652 | Fiorella et al. | Apr 2014 | B2 |
8702704 | Shelton, IV et al. | Apr 2014 | B2 |
8702724 | Olsen et al. | Apr 2014 | B2 |
8777919 | Kimura et al. | Jul 2014 | B2 |
8777976 | Brady et al. | Jul 2014 | B2 |
8777979 | Shrivastava et al. | Jul 2014 | B2 |
8784434 | Rosenbluth et al. | Jul 2014 | B2 |
8784441 | Rosenbluth et al. | Jul 2014 | B2 |
8795305 | Martin et al. | Aug 2014 | B2 |
8795317 | Grandfield et al. | Aug 2014 | B2 |
8795345 | Grandfield et al. | Aug 2014 | B2 |
8814892 | Galdonik et al. | Aug 2014 | B2 |
8814925 | Hilaire et al. | Aug 2014 | B2 |
8852205 | Brady et al. | Oct 2014 | B2 |
8870941 | Evans et al. | Oct 2014 | B2 |
8900265 | Ulm, III | Dec 2014 | B1 |
8920358 | Levine et al. | Dec 2014 | B2 |
8939991 | Krolik et al. | Jan 2015 | B2 |
8945143 | Ferrera et al. | Feb 2015 | B2 |
8945160 | Krolik et al. | Feb 2015 | B2 |
8945169 | Pal | Feb 2015 | B2 |
8945172 | Ferrera et al. | Feb 2015 | B2 |
8956399 | Cam et al. | Feb 2015 | B2 |
8968330 | Rosenbluth et al. | Mar 2015 | B2 |
9011481 | Aggerholm et al. | Apr 2015 | B2 |
9039749 | Shrivastava et al. | May 2015 | B2 |
9072537 | Grandfield et al. | Jul 2015 | B2 |
9095342 | Becking et al. | Aug 2015 | B2 |
9113936 | Palmer et al. | Aug 2015 | B2 |
9119656 | Bose et al. | Sep 2015 | B2 |
9138307 | Valaie | Sep 2015 | B2 |
9155552 | Ulm, III | Oct 2015 | B2 |
9161758 | Figulla et al. | Oct 2015 | B2 |
9161766 | Slee et al. | Oct 2015 | B2 |
9173668 | Ulm, III | Nov 2015 | B2 |
9173688 | Dosta | Nov 2015 | B2 |
9186487 | Dubrul et al. | Nov 2015 | B2 |
9198687 | Fulkerson et al. | Dec 2015 | B2 |
9204887 | Cully et al. | Dec 2015 | B2 |
9211132 | Bowman | Dec 2015 | B2 |
9232992 | Heidner et al. | Jan 2016 | B2 |
9254371 | Martin et al. | Feb 2016 | B2 |
9301769 | Brady et al. | Apr 2016 | B2 |
9332999 | Ray et al. | May 2016 | B2 |
9402707 | Brady et al. | Aug 2016 | B2 |
9445829 | Brady et al. | Sep 2016 | B2 |
9456834 | Folk | Oct 2016 | B2 |
9532792 | Galdonik et al. | Jan 2017 | B2 |
9532873 | Kelley | Jan 2017 | B2 |
9533344 | Monetti et al. | Jan 2017 | B2 |
9539011 | Chen et al. | Jan 2017 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9539122 | Burke et al. | Jan 2017 | B2 |
9539382 | Nelson | Jan 2017 | B2 |
9549830 | Bruszewski et al. | Jan 2017 | B2 |
9554805 | Tompkins et al. | Jan 2017 | B2 |
9561125 | Bowman et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9579104 | Beckham et al. | Feb 2017 | B2 |
9579484 | Barnell | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9615832 | Bose et al. | Apr 2017 | B2 |
9615951 | Bennett et al. | Apr 2017 | B2 |
9622753 | Cox | Apr 2017 | B2 |
9636115 | Henry et al. | May 2017 | B2 |
9636439 | Chu et al. | May 2017 | B2 |
9642639 | Brady et al. | May 2017 | B2 |
9642675 | Werneth et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9655645 | Staunton | May 2017 | B2 |
9655898 | Palepu et al. | May 2017 | B2 |
9655989 | Cruise et al. | May 2017 | B2 |
9662129 | Galdonik et al. | May 2017 | B2 |
9662238 | Dwork et al. | May 2017 | B2 |
9662425 | Lilja et al. | May 2017 | B2 |
9668898 | Wong | Jun 2017 | B2 |
9675477 | Thompson | Jun 2017 | B2 |
9675782 | Connolly | Jun 2017 | B2 |
9676022 | Ensign et al. | Jun 2017 | B2 |
9692557 | Murphy | Jun 2017 | B2 |
9693852 | Lam et al. | Jul 2017 | B2 |
9700262 | Janik et al. | Jul 2017 | B2 |
9700399 | Acosta-Acevedo | Jul 2017 | B2 |
9717421 | Griswold et al. | Aug 2017 | B2 |
9717500 | Tieu et al. | Aug 2017 | B2 |
9717502 | Teoh et al. | Aug 2017 | B2 |
9724103 | Cruise et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9750565 | Bloom et al. | Sep 2017 | B2 |
9757260 | Greenan | Sep 2017 | B2 |
9758606 | Lambert et al. | Sep 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9770251 | Bowman et al. | Sep 2017 | B2 |
9770577 | Li et al. | Sep 2017 | B2 |
9775621 | Tompkins et al. | Oct 2017 | B2 |
9775706 | Peterson et al. | Oct 2017 | B2 |
9775732 | Khenansho | Oct 2017 | B2 |
9788800 | Mayoras, Jr. | Oct 2017 | B2 |
9795391 | Saatchi et al. | Oct 2017 | B2 |
9801651 | Harrah et al. | Oct 2017 | B2 |
9801980 | Karino et al. | Oct 2017 | B2 |
9808599 | Bowman et al. | Nov 2017 | B2 |
9833252 | Sepetka et al. | Dec 2017 | B2 |
9833304 | Horan et al. | Dec 2017 | B2 |
9833604 | Lam et al. | Dec 2017 | B2 |
9833625 | Waldhauser et al. | Dec 2017 | B2 |
9901434 | Hoffman | Feb 2018 | B2 |
9918720 | Marchand et al. | Mar 2018 | B2 |
9939361 | Gaji et al. | Apr 2018 | B2 |
10016206 | Yang | Jul 2018 | B1 |
10070878 | Ma | Sep 2018 | B2 |
10098651 | Marchand et al. | Oct 2018 | B2 |
10201360 | Vale et al. | Feb 2019 | B2 |
10231751 | Sos | Mar 2019 | B2 |
10292723 | Brady et al. | May 2019 | B2 |
10299811 | Brady et al. | May 2019 | B2 |
10363054 | Vale et al. | Jul 2019 | B2 |
10376274 | Farin et al. | Aug 2019 | B2 |
10390850 | Vale et al. | Aug 2019 | B2 |
10524811 | Marchand et al. | Jan 2020 | B2 |
10531942 | Eggers | Jan 2020 | B2 |
10617435 | Vale et al. | Apr 2020 | B2 |
10722257 | Skillrud et al. | Jul 2020 | B2 |
11439418 | O'Malley | Sep 2022 | B2 |
11517340 | Casey | Dec 2022 | B2 |
20010001315 | Bates et al. | May 2001 | A1 |
20010016755 | Addis | Aug 2001 | A1 |
20010037141 | Yee et al. | Nov 2001 | A1 |
20010037171 | Sato | Nov 2001 | A1 |
20010041909 | Tsugita et al. | Nov 2001 | A1 |
20010044632 | Daniel et al. | Nov 2001 | A1 |
20010049554 | Ruiz et al. | Dec 2001 | A1 |
20010051810 | Dubrul et al. | Dec 2001 | A1 |
20020004667 | Adams et al. | Jan 2002 | A1 |
20020016609 | Wensel et al. | Feb 2002 | A1 |
20020022859 | Ogendijk | Feb 2002 | A1 |
20020026211 | Khosravi et al. | Feb 2002 | A1 |
20020042627 | Brady et al. | Apr 2002 | A1 |
20020049468 | Streeter et al. | Apr 2002 | A1 |
20020052620 | Barbut | May 2002 | A1 |
20020058911 | Gilson et al. | May 2002 | A1 |
20020068954 | Foster | Jun 2002 | A1 |
20020072764 | Sepetka et al. | Jun 2002 | A1 |
20020082558 | Samson et al. | Jun 2002 | A1 |
20020091407 | Zadno-Azizi | Jul 2002 | A1 |
20020095171 | Belef | Jul 2002 | A1 |
20020123765 | Sepetka et al. | Sep 2002 | A1 |
20020128680 | Pavolvic | Sep 2002 | A1 |
20020138094 | Borillo et al. | Sep 2002 | A1 |
20020143349 | Gifford, III et al. | Oct 2002 | A1 |
20020143362 | Macoviak et al. | Oct 2002 | A1 |
20020156455 | Barbut | Oct 2002 | A1 |
20020161393 | Demond et al. | Oct 2002 | A1 |
20020165576 | Boyle et al. | Nov 2002 | A1 |
20020173819 | Eeflang et al. | Nov 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20020188276 | Evans et al. | Dec 2002 | A1 |
20020188314 | Anderson et al. | Dec 2002 | A1 |
20020193824 | Boylan et al. | Dec 2002 | A1 |
20020198588 | Armstrong et al. | Dec 2002 | A1 |
20030004536 | Boylan | Jan 2003 | A1 |
20030004538 | Secrest et al. | Jan 2003 | A1 |
20030004540 | Linder et al. | Jan 2003 | A1 |
20030004542 | Wensel et al. | Jan 2003 | A1 |
20030009146 | Muni et al. | Jan 2003 | A1 |
20030009191 | Wensel et al. | Jan 2003 | A1 |
20030038447 | Cantele | Feb 2003 | A1 |
20030040772 | Hyodoh et al. | Feb 2003 | A1 |
20030050663 | Khachin et al. | Mar 2003 | A1 |
20030064151 | Klinedinst | Apr 2003 | A1 |
20030069520 | Skujins et al. | Apr 2003 | A1 |
20030108224 | Ike | Jun 2003 | A1 |
20030114879 | Euteneuer et al. | Jun 2003 | A1 |
20030125798 | Martin | Jul 2003 | A1 |
20030130682 | Broome et al. | Jul 2003 | A1 |
20030144687 | Brady et al. | Jul 2003 | A1 |
20030144688 | Brady et al. | Jul 2003 | A1 |
20030153158 | Ho et al. | Aug 2003 | A1 |
20030153943 | Michael et al. | Aug 2003 | A1 |
20030153944 | Phung et al. | Aug 2003 | A1 |
20030163064 | Vrba et al. | Aug 2003 | A1 |
20030163158 | White | Aug 2003 | A1 |
20030171769 | Barbut | Sep 2003 | A1 |
20030171771 | Anderson et al. | Sep 2003 | A1 |
20030176884 | Berrada et al. | Sep 2003 | A1 |
20030187495 | Cully et al. | Oct 2003 | A1 |
20030195537 | Dubrul et al. | Oct 2003 | A1 |
20030195554 | Shen et al. | Oct 2003 | A1 |
20030199917 | Knudson et al. | Oct 2003 | A1 |
20030204202 | Palmer et al. | Oct 2003 | A1 |
20030208224 | Broome | Nov 2003 | A1 |
20030212430 | Bose et al. | Nov 2003 | A1 |
20030236533 | Wilson et al. | Dec 2003 | A1 |
20040064179 | Linder et al. | Apr 2004 | A1 |
20040068288 | Palmer et al. | Apr 2004 | A1 |
20040073243 | Sepetka et al. | Apr 2004 | A1 |
20040079429 | Miller et al. | Apr 2004 | A1 |
20040082962 | Demarais et al. | Apr 2004 | A1 |
20040082967 | Broome | Apr 2004 | A1 |
20040088001 | Bosma et al. | May 2004 | A1 |
20040093065 | Yachia et al. | May 2004 | A1 |
20040098050 | Foerster et al. | May 2004 | A1 |
20040133231 | Maitland et al. | Jul 2004 | A1 |
20040133232 | Rosenbluth et al. | Jul 2004 | A1 |
20040138692 | Phung et al. | Jul 2004 | A1 |
20040153117 | Clubb et al. | Aug 2004 | A1 |
20040153118 | Clubb et al. | Aug 2004 | A1 |
20040199201 | Kellett et al. | Oct 2004 | A1 |
20040204749 | Gunderson | Oct 2004 | A1 |
20040215318 | Kwitkin | Oct 2004 | A1 |
20040220663 | Rivelli | Nov 2004 | A1 |
20050010245 | Wasicek | Jan 2005 | A1 |
20050033248 | Machida et al. | Feb 2005 | A1 |
20050033348 | Sepetka et al. | Feb 2005 | A1 |
20050038447 | Huffmaster | Feb 2005 | A1 |
20050038468 | Panetta et al. | Feb 2005 | A1 |
20050043759 | Chanduszko | Feb 2005 | A1 |
20050049619 | Sepetka et al. | Mar 2005 | A1 |
20050049669 | Jones et al. | Mar 2005 | A1 |
20050049670 | Jones et al. | Mar 2005 | A1 |
20050055033 | Leslie et al. | Mar 2005 | A1 |
20050055047 | Greenhalgh | Mar 2005 | A1 |
20050058837 | Farnworth et al. | Mar 2005 | A1 |
20050059995 | Sepetka et al. | Mar 2005 | A1 |
20050085849 | Sepetka et al. | Apr 2005 | A1 |
20050090779 | Osypka | Apr 2005 | A1 |
20050090857 | Kusleika et al. | Apr 2005 | A1 |
20050125024 | Sepetka et al. | Jun 2005 | A1 |
20050149997 | Wolozin et al. | Jul 2005 | A1 |
20050171566 | Kanamaru | Aug 2005 | A1 |
20050173135 | Almen | Aug 2005 | A1 |
20050192627 | Whisenant et al. | Sep 2005 | A1 |
20050215942 | Abrahamson et al. | Sep 2005 | A1 |
20050216030 | Sepetka et al. | Sep 2005 | A1 |
20050216050 | Sepetka et al. | Sep 2005 | A1 |
20050228417 | Teitelbaum et al. | Oct 2005 | A1 |
20050251206 | Maahs et al. | Nov 2005 | A1 |
20050251209 | Saadat et al. | Nov 2005 | A1 |
20050267491 | Kellett et al. | Dec 2005 | A1 |
20050273135 | Chanduszko et al. | Dec 2005 | A1 |
20050283186 | Berrada et al. | Dec 2005 | A1 |
20050288686 | Sepetka et al. | Dec 2005 | A1 |
20060008332 | Greenberg et al. | Jan 2006 | A1 |
20060009798 | Callister et al. | Jan 2006 | A1 |
20060009799 | Kleshinski et al. | Jan 2006 | A1 |
20060020285 | Niermann | Jan 2006 | A1 |
20060020286 | Niermann | Jan 2006 | A1 |
20060030877 | Martinez et al. | Feb 2006 | A1 |
20060041228 | Vo et al. | Feb 2006 | A1 |
20060058836 | Bose et al. | Mar 2006 | A1 |
20060058837 | Bose et al. | Mar 2006 | A1 |
20060058838 | Bose et al. | Mar 2006 | A1 |
20060064151 | Guterman et al. | Mar 2006 | A1 |
20060069424 | Acosta et al. | Mar 2006 | A1 |
20060074477 | Berthiaume et al. | Apr 2006 | A1 |
20060142838 | Molaei et al. | Jun 2006 | A1 |
20060149313 | Arguello et al. | Jul 2006 | A1 |
20060155305 | Freudenthal et al. | Jul 2006 | A1 |
20060161187 | Evine et al. | Jul 2006 | A1 |
20060195137 | Sepetka et al. | Aug 2006 | A1 |
20060224177 | Finitsis | Oct 2006 | A1 |
20060224179 | Kucharczyk et al. | Oct 2006 | A1 |
20060229638 | Abrams et al. | Oct 2006 | A1 |
20060235501 | Igaki | Oct 2006 | A1 |
20060241677 | Johnson et al. | Oct 2006 | A1 |
20060282111 | Morsi | Dec 2006 | A1 |
20060287668 | Fawzi et al. | Dec 2006 | A1 |
20060287701 | Pal | Dec 2006 | A1 |
20060293706 | Shimon | Dec 2006 | A1 |
20070010857 | Sugimoto et al. | Jan 2007 | A1 |
20070032879 | Levine et al. | Feb 2007 | A1 |
20070088382 | Bei et al. | Apr 2007 | A1 |
20070088383 | Pal | Apr 2007 | A1 |
20070100348 | Cauthen, III et al. | May 2007 | A1 |
20070118173 | Magnuson et al. | May 2007 | A1 |
20070149997 | Muller | Jun 2007 | A1 |
20070156170 | Hancock et al. | Jul 2007 | A1 |
20070165170 | Fukuda | Jul 2007 | A1 |
20070179527 | Eskuri et al. | Aug 2007 | A1 |
20070191866 | Palmer et al. | Aug 2007 | A1 |
20070198028 | Miloslavski et al. | Aug 2007 | A1 |
20070198051 | Clubb et al. | Aug 2007 | A1 |
20070198075 | Levy | Aug 2007 | A1 |
20070208367 | Fiorella et al. | Sep 2007 | A1 |
20070208371 | French et al. | Sep 2007 | A1 |
20070225749 | Martin et al. | Sep 2007 | A1 |
20070233175 | Zaver et al. | Oct 2007 | A1 |
20070244505 | Gilson et al. | Oct 2007 | A1 |
20070270902 | Slazas et al. | Nov 2007 | A1 |
20070288054 | Tanaka et al. | Dec 2007 | A1 |
20080045881 | Teitelbaum et al. | Feb 2008 | A1 |
20080077227 | Ouellette et al. | Mar 2008 | A1 |
20080082107 | Miller et al. | Apr 2008 | A1 |
20080086190 | Ta | Apr 2008 | A1 |
20080091223 | Pokorney et al. | Apr 2008 | A1 |
20080097386 | Osypka | Apr 2008 | A1 |
20080109031 | Sepetka et al. | May 2008 | A1 |
20080109032 | Sepetka et al. | May 2008 | A1 |
20080119886 | Greenhalgh et al. | May 2008 | A1 |
20080125798 | Osborne et al. | May 2008 | A1 |
20080177296 | Sepetka et al. | Jul 2008 | A1 |
20080178890 | Townsend et al. | Jul 2008 | A1 |
20080183197 | Sepetka et al. | Jul 2008 | A1 |
20080183198 | Sepetka et al. | Jul 2008 | A1 |
20080183205 | Sepetka et al. | Jul 2008 | A1 |
20080188876 | Sepetka et al. | Aug 2008 | A1 |
20080188885 | Sepetka et al. | Aug 2008 | A1 |
20080188887 | Batiste | Aug 2008 | A1 |
20080200946 | Braun et al. | Aug 2008 | A1 |
20080200947 | Kusleika et al. | Aug 2008 | A1 |
20080215077 | Sepetka et al. | Sep 2008 | A1 |
20080221600 | Dieck et al. | Sep 2008 | A1 |
20080228209 | DeMello et al. | Sep 2008 | A1 |
20080234706 | Sepetka et al. | Sep 2008 | A1 |
20080243170 | Jenson et al. | Oct 2008 | A1 |
20080255596 | Jenson et al. | Oct 2008 | A1 |
20080262410 | Jenson et al. | Oct 2008 | A1 |
20080262528 | Martin | Oct 2008 | A1 |
20080262532 | Martin | Oct 2008 | A1 |
20080262590 | Murray | Oct 2008 | A1 |
20080269871 | Eli | Oct 2008 | A1 |
20080275488 | Fleming | Nov 2008 | A1 |
20080275493 | Farmiga | Nov 2008 | A1 |
20080281350 | Sepetka et al. | Nov 2008 | A1 |
20080312681 | Ansel et al. | Dec 2008 | A1 |
20090005858 | Young et al. | Jan 2009 | A1 |
20090024157 | Anukhin | Jan 2009 | A1 |
20090030443 | Buser et al. | Jan 2009 | A1 |
20090062841 | Amplatz et al. | Mar 2009 | A1 |
20090069828 | Martin et al. | Mar 2009 | A1 |
20090076539 | Valaie | Mar 2009 | A1 |
20090088793 | Bagaoisan et al. | Apr 2009 | A1 |
20090088795 | Cahill | Apr 2009 | A1 |
20090105722 | Fulkerson et al. | Apr 2009 | A1 |
20090105737 | Fulkerson et al. | Apr 2009 | A1 |
20090105747 | Chanduszko et al. | Apr 2009 | A1 |
20090149881 | Vale et al. | Jun 2009 | A1 |
20090163851 | Holloway et al. | Jun 2009 | A1 |
20090177206 | Lozier et al. | Jul 2009 | A1 |
20090182336 | Brenzel et al. | Jul 2009 | A1 |
20090281610 | Parker | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287229 | Ogdahl | Nov 2009 | A1 |
20090292297 | Ferrere | Nov 2009 | A1 |
20090292307 | Razack | Nov 2009 | A1 |
20090299393 | Martin et al. | Dec 2009 | A1 |
20090299403 | Chanduszko et al. | Dec 2009 | A1 |
20090306702 | Miloslavski et al. | Dec 2009 | A1 |
20090326636 | Hashimoto et al. | Dec 2009 | A1 |
20100004607 | Wilson et al. | Jan 2010 | A1 |
20100076482 | Shu et al. | Mar 2010 | A1 |
20100087850 | Razack | Apr 2010 | A1 |
20100087908 | Hilaire et al. | Apr 2010 | A1 |
20100114017 | Lenker et al. | May 2010 | A1 |
20100125326 | Kalstad et al. | May 2010 | A1 |
20100125327 | Agnew | May 2010 | A1 |
20100191272 | Keating | Jul 2010 | A1 |
20100211094 | Sargent, Jr. | Aug 2010 | A1 |
20100268264 | Bonnette et al. | Oct 2010 | A1 |
20100268265 | Krolik et al. | Oct 2010 | A1 |
20100274277 | Eaton | Oct 2010 | A1 |
20100318178 | Rapaport et al. | Dec 2010 | A1 |
20100324649 | Mattsson et al. | Dec 2010 | A1 |
20100331949 | Habib | Dec 2010 | A1 |
20110009875 | Grandfield et al. | Jan 2011 | A1 |
20110009940 | Grandfield et al. | Jan 2011 | A1 |
20110009950 | Grandfield et al. | Jan 2011 | A1 |
20110015718 | Schreck | Jan 2011 | A1 |
20110022149 | Cox et al. | Jan 2011 | A1 |
20110040319 | Fulton, III | Feb 2011 | A1 |
20110054287 | Schultz | Mar 2011 | A1 |
20110054504 | Porter | Mar 2011 | A1 |
20110054514 | Arcand et al. | Mar 2011 | A1 |
20110054516 | Keegan et al. | Mar 2011 | A1 |
20110060212 | Slee et al. | Mar 2011 | A1 |
20110060359 | Hannes et al. | Mar 2011 | A1 |
20110106137 | Shimon | May 2011 | A1 |
20110125181 | Brady et al. | May 2011 | A1 |
20110152920 | Eckhouse et al. | Jun 2011 | A1 |
20110160763 | Ferrera et al. | Jun 2011 | A1 |
20110166586 | Sepetka et al. | Jul 2011 | A1 |
20110184456 | Grandfield et al. | Jul 2011 | A1 |
20110196414 | Porter et al. | Aug 2011 | A1 |
20110202088 | Eckhouse et al. | Aug 2011 | A1 |
20110208233 | McGuckin, Jr. et al. | Aug 2011 | A1 |
20110213297 | Aklog et al. | Sep 2011 | A1 |
20110213393 | Aklog et al. | Sep 2011 | A1 |
20110213403 | Aboytes | Sep 2011 | A1 |
20110224707 | Miloslavski et al. | Sep 2011 | A1 |
20110270374 | Orr et al. | Nov 2011 | A1 |
20110276120 | Gilson et al. | Nov 2011 | A1 |
20110319917 | Ferrera et al. | Dec 2011 | A1 |
20120041449 | Eckhouse et al. | Feb 2012 | A1 |
20120041474 | Eckhouse et al. | Feb 2012 | A1 |
20120059356 | di Palma et al. | Mar 2012 | A1 |
20120065660 | Ferrera et al. | Mar 2012 | A1 |
20120083823 | Shrivastava et al. | Apr 2012 | A1 |
20120083868 | Shrivastava et al. | Apr 2012 | A1 |
20120089216 | Rapaport et al. | Apr 2012 | A1 |
20120101510 | Lenker et al. | Apr 2012 | A1 |
20120116440 | Leynov et al. | May 2012 | A1 |
20120123466 | Porter et al. | May 2012 | A1 |
20120022572 | Braun et al. | Jun 2012 | A1 |
20120143230 | Sepetka et al. | Jun 2012 | A1 |
20120143237 | Cam et al. | Jun 2012 | A1 |
20120143317 | Cam et al. | Jun 2012 | A1 |
20120150147 | Leynov et al. | Jun 2012 | A1 |
20120165858 | Eckhouse et al. | Jun 2012 | A1 |
20120165859 | Eckhouse et al. | Jun 2012 | A1 |
20120209312 | Aggerholm et al. | Aug 2012 | A1 |
20120215250 | Grandfield et al. | Aug 2012 | A1 |
20120277788 | Cattaneo | Nov 2012 | A1 |
20120283768 | Cox et al. | Nov 2012 | A1 |
20120296362 | Cam et al. | Nov 2012 | A1 |
20120316600 | Ferrera et al. | Dec 2012 | A1 |
20120330350 | Jones et al. | Dec 2012 | A1 |
20130030460 | Marks et al. | Jan 2013 | A1 |
20130030461 | Marks et al. | Jan 2013 | A1 |
20130046330 | McIntosh | Feb 2013 | A1 |
20130046333 | Jones et al. | Feb 2013 | A1 |
20130046334 | Jones et al. | Feb 2013 | A1 |
20130116774 | Strauss et al. | May 2013 | A1 |
20130131614 | Hassan et al. | May 2013 | A1 |
20130144311 | Fung et al. | Jun 2013 | A1 |
20130144326 | Brady et al. | Jun 2013 | A1 |
20130158591 | Koehler | Jun 2013 | A1 |
20130158592 | Porter | Jun 2013 | A1 |
20130184739 | Brady et al. | Jul 2013 | A1 |
20130197567 | Brady et al. | Aug 2013 | A1 |
20130226146 | Tekulve | Aug 2013 | A1 |
20130268050 | Wilson et al. | Oct 2013 | A1 |
20130271788 | Utsunomiya | Oct 2013 | A1 |
20130277079 | Tsuzuki et al. | Oct 2013 | A1 |
20130281788 | Garrison | Oct 2013 | A1 |
20130325051 | Martin et al. | Dec 2013 | A1 |
20130325055 | Eckhouse et al. | Dec 2013 | A1 |
20130325056 | Eckhouse et al. | Dec 2013 | A1 |
20130345739 | Brady et al. | Dec 2013 | A1 |
20140005712 | Martin | Jan 2014 | A1 |
20140005713 | Bowman | Jan 2014 | A1 |
20140046359 | Bowman et al. | Feb 2014 | A1 |
20140088678 | Wainwright et al. | Mar 2014 | A1 |
20140121672 | Folk | May 2014 | A1 |
20140128905 | Molaei | May 2014 | A1 |
20140134654 | Rudel et al. | May 2014 | A1 |
20140135812 | Divino et al. | May 2014 | A1 |
20140142598 | Fulton, III | May 2014 | A1 |
20140163367 | Eskuri | Jun 2014 | A1 |
20140180122 | Stigall et al. | Jun 2014 | A1 |
20140180377 | Bose et al. | Jun 2014 | A1 |
20140180397 | Gerberding et al. | Jun 2014 | A1 |
20140183077 | Rosendall et al. | Jul 2014 | A1 |
20140194911 | Johnson et al. | Jul 2014 | A1 |
20140194919 | Losordo et al. | Jul 2014 | A1 |
20140200607 | Sepetka et al. | Jul 2014 | A1 |
20140200608 | Brady et al. | Jul 2014 | A1 |
20140236220 | Inoue | Aug 2014 | A1 |
20140243881 | Lees et al. | Aug 2014 | A1 |
20140257362 | Eidenschink | Sep 2014 | A1 |
20140276922 | McLain et al. | Sep 2014 | A1 |
20140277079 | Vale et al. | Sep 2014 | A1 |
20140303667 | Cox et al. | Oct 2014 | A1 |
20140309657 | Ben-Ami | Oct 2014 | A1 |
20140309673 | Dacuycuy et al. | Oct 2014 | A1 |
20140330302 | Tekulve et al. | Nov 2014 | A1 |
20140343585 | Ferrera et al. | Nov 2014 | A1 |
20140371769 | Vale et al. | Dec 2014 | A1 |
20140371779 | Vale et al. | Dec 2014 | A1 |
20140371780 | Vale et al. | Dec 2014 | A1 |
20140372779 | Wong et al. | Dec 2014 | A1 |
20140379023 | Brady et al. | Dec 2014 | A1 |
20150018859 | Quick et al. | Jan 2015 | A1 |
20150018860 | Quick et al. | Jan 2015 | A1 |
20150032144 | Holloway | Jan 2015 | A1 |
20150080937 | Davidson | Mar 2015 | A1 |
20150112376 | Molaei et al. | Apr 2015 | A1 |
20150133990 | Davidson | May 2015 | A1 |
20150150672 | Ma | Jun 2015 | A1 |
20150164523 | Brady et al. | Jun 2015 | A1 |
20150224133 | Ohri et al. | Aug 2015 | A1 |
20150250497 | Marks et al. | Sep 2015 | A1 |
20150257775 | Gilvarry et al. | Sep 2015 | A1 |
20150272716 | Pinchuk et al. | Oct 2015 | A1 |
20150297252 | Miloslavski et al. | Oct 2015 | A1 |
20150313617 | Grandfield et al. | Nov 2015 | A1 |
20150320431 | John | Nov 2015 | A1 |
20150352325 | Quick | Dec 2015 | A1 |
20150359547 | Vale et al. | Dec 2015 | A1 |
20150366650 | Zi et al. | Dec 2015 | A1 |
20150374391 | Quick et al. | Dec 2015 | A1 |
20150374393 | Brady et al. | Dec 2015 | A1 |
20150374479 | Vale | Dec 2015 | A1 |
20160015402 | Brady et al. | Jan 2016 | A1 |
20160022269 | Ganske et al. | Jan 2016 | A1 |
20160022296 | Brady et al. | Jan 2016 | A1 |
20160045298 | Thinnes, Jr. et al. | Feb 2016 | A1 |
20160066921 | Seifert et al. | Mar 2016 | A1 |
20160100928 | Lees et al. | Apr 2016 | A1 |
20160106448 | Brady et al. | Apr 2016 | A1 |
20160106449 | Brady et al. | Apr 2016 | A1 |
20160113663 | Brady et al. | Apr 2016 | A1 |
20160113664 | Brady et al. | Apr 2016 | A1 |
20160113665 | Brady et al. | Apr 2016 | A1 |
20160120558 | Brady et al. | May 2016 | A1 |
20160143653 | Vale et al. | May 2016 | A1 |
20160192953 | Brady et al. | Jul 2016 | A1 |
20160192954 | Brady et al. | Jul 2016 | A1 |
20160192955 | Brady et al. | Jul 2016 | A1 |
20160192956 | Brady et al. | Jul 2016 | A1 |
20160256180 | Vale et al. | Sep 2016 | A1 |
20160303381 | Pierce et al. | Oct 2016 | A1 |
20160317168 | Brady et al. | Nov 2016 | A1 |
20170007264 | Cruise et al. | Jan 2017 | A1 |
20170007265 | Guo et al. | Jan 2017 | A1 |
20170020542 | Martin et al. | Jan 2017 | A1 |
20170020670 | Murray et al. | Jan 2017 | A1 |
20170020700 | Bienvenu et al. | Jan 2017 | A1 |
20170027640 | Kunis et al. | Feb 2017 | A1 |
20170027692 | Bonhoeffer et al. | Feb 2017 | A1 |
20170027725 | Argentine | Feb 2017 | A1 |
20170035436 | Morita | Feb 2017 | A1 |
20170035567 | Duffy | Feb 2017 | A1 |
20170042548 | Lam | Feb 2017 | A1 |
20170049596 | Schabert | Feb 2017 | A1 |
20170056061 | Ogle et al. | Mar 2017 | A1 |
20170071614 | Vale et al. | Mar 2017 | A1 |
20170071737 | Kelley | Mar 2017 | A1 |
20170072452 | Monetti et al. | Mar 2017 | A1 |
20170079671 | Morero et al. | Mar 2017 | A1 |
20170079680 | Bowman | Mar 2017 | A1 |
20170079766 | Wang et al. | Mar 2017 | A1 |
20170079767 | Leon-Yip | Mar 2017 | A1 |
20170079812 | Am et al. | Mar 2017 | A1 |
20170079817 | Sepetka et al. | Mar 2017 | A1 |
20170079819 | Pung et al. | Mar 2017 | A1 |
20170079820 | Lam et al. | Mar 2017 | A1 |
20170086851 | Wallace et al. | Mar 2017 | A1 |
20170086862 | Vale et al. | Mar 2017 | A1 |
20170086863 | Brady et al. | Mar 2017 | A1 |
20170086996 | Peterson et al. | Mar 2017 | A1 |
20170095259 | Tompkins et al. | Apr 2017 | A1 |
20170100126 | Bowman et al. | Apr 2017 | A1 |
20170100141 | Morero et al. | Apr 2017 | A1 |
20170100143 | Grandfield | Apr 2017 | A1 |
20170100183 | Aizzo et al. | Apr 2017 | A1 |
20170105743 | Vale et al. | Apr 2017 | A1 |
20170112515 | Brady et al. | Apr 2017 | A1 |
20170112647 | Sachar et al. | Apr 2017 | A1 |
20170113023 | Steingisser et al. | Apr 2017 | A1 |
20170119409 | Ma | May 2017 | A1 |
20170143465 | Ulm, III | May 2017 | A1 |
20170147765 | Mehta | May 2017 | A1 |
20170150979 | John | Jun 2017 | A1 |
20170151032 | Loisel | Jun 2017 | A1 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165065 | Rothstein et al. | Jun 2017 | A1 |
20170165454 | Tuohy et al. | Jun 2017 | A1 |
20170172581 | Bose et al. | Jun 2017 | A1 |
20170172766 | Vong et al. | Jun 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
20170189033 | Sepetka et al. | Jul 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170189041 | Cox et al. | Jul 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170216484 | Cruise et al. | Aug 2017 | A1 |
20170224350 | Shimizu et al. | Aug 2017 | A1 |
20170224355 | Bowman et al. | Aug 2017 | A1 |
20170224467 | Piccagli et al. | Aug 2017 | A1 |
20170224511 | Dwork et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170231749 | Perkins et al. | Aug 2017 | A1 |
20170252064 | Staunton | Sep 2017 | A1 |
20170265983 | Lam et al. | Sep 2017 | A1 |
20170281192 | Tieu et al. | Oct 2017 | A1 |
20170281331 | Perkins et al. | Oct 2017 | A1 |
20170281344 | Costello | Oct 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170281912 | Melder et al. | Oct 2017 | A1 |
20170290593 | Cruise et al. | Oct 2017 | A1 |
20170290654 | Sethna | Oct 2017 | A1 |
20170296324 | Argentine | Oct 2017 | A1 |
20170296325 | Marrocco et al. | Oct 2017 | A1 |
20170303939 | Greenhalgh et al. | Oct 2017 | A1 |
20170303942 | Greenhalgh | Oct 2017 | A1 |
20170303947 | Greenhalgh et al. | Oct 2017 | A1 |
20170303948 | Wallace et al. | Oct 2017 | A1 |
20170304041 | Argentine | Oct 2017 | A1 |
20170304097 | Corwin et al. | Oct 2017 | A1 |
20170304595 | Nagasrinivasa et al. | Oct 2017 | A1 |
20170312109 | Le | Nov 2017 | A1 |
20170312484 | Shipley et al. | Nov 2017 | A1 |
20170316561 | Helm et al. | Nov 2017 | A1 |
20170319826 | Bowman et al. | Nov 2017 | A1 |
20170333228 | Orth et al. | Nov 2017 | A1 |
20170333236 | Greenan | Nov 2017 | A1 |
20170333678 | Bowman et al. | Nov 2017 | A1 |
20170340383 | Bloom et al. | Nov 2017 | A1 |
20170348014 | Wallace et al. | Dec 2017 | A1 |
20170348514 | Guyon et al. | Dec 2017 | A1 |
20180140315 | Bowman et al. | May 2018 | A1 |
20180206865 | Martin et al. | Jul 2018 | A1 |
20180207399 | Chou et al. | Jul 2018 | A1 |
20180263650 | Wanami et al. | Sep 2018 | A1 |
20180325537 | Shamay et al. | Nov 2018 | A1 |
20180326024 | Prochazka et al. | Nov 2018 | A1 |
20180344338 | Brady et al. | Dec 2018 | A1 |
20190000492 | Casey et al. | Jan 2019 | A1 |
20190015061 | Liebeskind et al. | Jan 2019 | A1 |
20190167284 | Friedman et al. | Jun 2019 | A1 |
20190239907 | Brady | Aug 2019 | A1 |
20190292273 | Hanotin et al. | Sep 2019 | A1 |
20190374239 | Martin et al. | Dec 2019 | A1 |
20190380723 | Grandfield et al. | Dec 2019 | A1 |
20190388097 | Girdhar et al. | Dec 2019 | A1 |
20200000483 | Brady et al. | Jan 2020 | A1 |
20200009150 | Chamorro Sanchez | Jan 2020 | A1 |
20200085444 | Vale et al. | Mar 2020 | A1 |
20200100804 | Casey et al. | Apr 2020 | A1 |
20200297364 | Choe et al. | Sep 2020 | A1 |
20200390459 | Casey | Dec 2020 | A1 |
20210005321 | Hwang | Jan 2021 | A1 |
20210007757 | Casey et al. | Jan 2021 | A1 |
20210228223 | Casey et al. | Jul 2021 | A1 |
20220192739 | Deen et al. | Jun 2022 | A1 |
Number | Date | Country |
---|---|---|
2557083 | Jun 2003 | CN |
101172051 | May 2008 | CN |
102307613 | Jan 2012 | CN |
102316809 | Jan 2012 | CN |
102596098 | Jul 2012 | CN |
103764049 | Apr 2014 | CN |
104042304 | Sep 2014 | CN |
105208950 | Dec 2015 | CN |
105662532 | Jun 2016 | CN |
205359559 | Jul 2016 | CN |
107530090 | Jan 2018 | CN |
208582467 | Mar 2019 | CN |
202009001951 | Mar 2010 | DE |
102009056450 | Jun 2011 | DE |
102010010849 | Sep 2011 | DE |
102010014778 | Oct 2011 | DE |
102010024085 | Dec 2011 | DE |
102011014586 | Sep 2012 | DE |
1153581 | Nov 2001 | EP |
2301450 | Mar 2011 | EP |
2438891 | Apr 2012 | EP |
2628455 | Aug 2013 | EP |
3156004 | Apr 2017 | EP |
3593742 | Jan 2020 | EP |
3669802 | Jun 2020 | EP |
3858291 | Aug 2021 | EP |
2210456 | Jul 2004 | ES |
2427554 | Jan 2007 | GB |
2494820 | Mar 2013 | GB |
H0919438 | Jan 1997 | JP |
2014511223 | May 2014 | JP |
2014525796 | Oct 2014 | JP |
2015-505250 | Feb 2015 | JP |
2016-513505 | May 2016 | JP |
2019-526365 | Sep 2019 | JP |
9424926 | Nov 1994 | WO |
9727808 | Aug 1997 | WO |
9738631 | Oct 1997 | WO |
9920335 | Apr 1999 | WO |
9956801 | Nov 1999 | WO |
9960933 | Dec 1999 | WO |
0121077 | Mar 2001 | WO |
0202162 | Jan 2002 | WO |
0211627 | Feb 2002 | WO |
0243616 | Jun 2002 | WO |
02070061 | Sep 2002 | WO |
02094111 | Nov 2002 | WO |
03002006 | Jan 2003 | WO |
03030751 | Apr 2003 | WO |
03051448 | Jun 2003 | WO |
2004028571 | Apr 2004 | WO |
2004056275 | Jul 2004 | WO |
2005000130 | Jan 2005 | WO |
2005027779 | Mar 2005 | WO |
2006021407 | Mar 2006 | WO |
2006031410 | Mar 2006 | WO |
2006107641 | Oct 2006 | WO |
2006135823 | Dec 2006 | WO |
2007054307 | May 2007 | WO |
2007068424 | Jun 2007 | WO |
2008034615 | Mar 2008 | WO |
2008051431 | May 2008 | WO |
2008131116 | Oct 2008 | WO |
2008135823 | Nov 2008 | WO |
2009031338 | Mar 2009 | WO |
2009076482 | Jun 2009 | WO |
2009086482 | Jul 2009 | WO |
2009105710 | Aug 2009 | WO |
2010010545 | Jan 2010 | WO |
2010046897 | Apr 2010 | WO |
2010075565 | Jul 2010 | WO |
2010102307 | Sep 2010 | WO |
2010146581 | Dec 2010 | WO |
2011013556 | Feb 2011 | WO |
2011066961 | Jun 2011 | WO |
2011082319 | Jul 2011 | WO |
2011095352 | Aug 2011 | WO |
2011106426 | Sep 2011 | WO |
2011110316 | Sep 2011 | WO |
2011135556 | Nov 2011 | WO |
2012052982 | Apr 2012 | WO |
2012064726 | May 2012 | WO |
2012081020 | Jun 2012 | WO |
2012110619 | Aug 2012 | WO |
2012120490 | Sep 2012 | WO |
2012156924 | Nov 2012 | WO |
2013016435 | Jan 2013 | WO |
2013072777 | May 2013 | WO |
2013105099 | Jul 2013 | WO |
2013109756 | Jul 2013 | WO |
2013187927 | Dec 2013 | WO |
2014047650 | Mar 2014 | WO |
2014081892 | May 2014 | WO |
2014139845 | Sep 2014 | WO |
2014169266 | Oct 2014 | WO |
2014178198 | Nov 2014 | WO |
2015061365 | Apr 2015 | WO |
2015103547 | Jul 2015 | WO |
2015134625 | Sep 2015 | WO |
2015179324 | Nov 2015 | WO |
2015189354 | Dec 2015 | WO |
2016010995 | Jan 2016 | WO |
2016089451 | Jun 2016 | WO |
2017089424 | Jun 2017 | WO |
WO 2017090473 | Jun 2017 | WO |
WO 2017103686 | Jun 2017 | WO |
WO 2017161204 | Sep 2017 | WO |
WO 2020039082 | Feb 2020 | WO |
WO 2021113302 | Jun 2021 | WO |
Entry |
---|
US 6,348,062 B1, 02/2002, Hopkins et al. (withdrawn) |
Extended European Search Report issued in European Patent Application No. 22 16 2599 dated Aug. 2, 2022. |
Number | Date | Country | |
---|---|---|---|
20220296262 A1 | Sep 2022 | US |